TDOC

Teladoc Health, Inc. (TDOC) - Q3 2025 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly period ended September 30, 2025. Teladoc Health operates as a global leader in virtual care with two primary reportable segments: Integrated Care (virtual medical services, chronic care management) and BetterHelp (virtual therapy and wellness). During the quarter, the Company completed acquisitions of Telecare Australia, Catapult Health, and Uplift Health Technologies, and relocated its principal executive office to New York, New York.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Total revenue decreased 2% year-over-year (Q3) and 2% year-to-date, driven primarily by an 8% revenue decline in the BetterHelp segment due to a 4% decrease in paying users. Integrated Care revenue grew 2% (Q3) and 3% (YTD), aided by recent acquisitions.
• Goodwill Impairments: The Company recorded $71.8 million in goodwill impairments year-to-date (including $12.6M in Q3) related to the Integrated Care reporting unit following the acquisitions of Telecare and Catapult Health. This compares to $790.0 million in impairments in the prior year.
• Debt Reduction: The Company repaid $550.0 million in Livongo Notes and $0.6 million in 2025 Notes upon maturity in May and June 2025. Only the $1.0 billion 2027 Convertible Senior Notes remain outstanding.
• Cost Management: Operating expenses decreased across most categories, including a 5% reduction in advertising and marketing and a 10% reduction in general and administrative expenses (Q3), offset by higher labor and technology costs in Cost of Revenue.
• Segment Performance: BetterHelp Adjusted EBITDA margin contracted significantly to 1.6% (Q3) from 5.9% (Q3 2024). Integrated Care Adjusted EBITDA margin was 17.0% (Q3), down slightly from 17.7% (Q3 2024).

Guidance, Outlook, and Risks

• Liquidity: The Company holds $726.2 million in cash and cash equivalents. Management believes this is sufficient to meet obligations for the next 12 months. A new $300 million revolving credit facility was established in July 2025, with no current borrowings.
• Outlook: Management anticipates continuing positive operating cash flows for 2025. The Company is evaluating initiatives to improve efficiency and expects to recognize related charges in Q4 2025.
• Risks & Contingencies:
  • Legal Proceedings: Multiple securities class actions remain pending, including appeals regarding the Schneider and Stary cases. BetterHelp faces multiple class actions regarding data privacy and advertising practices.
  • Goodwill Risk: If the carrying value of the Integrated Care reporting unit continues to exceed its fair value, future acquisitions could trigger further goodwill impairments.
  • Executive Departure: CFO Mala Murthy announced her resignation effective November 21, 2025. CEO Charles Divita, III will serve as interim CFO.
  • Macro Factors: Potential impacts from tariffs on imported medical device components and retaliatory trade measures.

Investor Verification Checklist

• Goodwill Valuation: Verify the assumptions used in the fair value assessment of the Integrated Care reporting unit given the recurring impairments.
• BetterHelp User Trends: Monitor the trajectory of paying users and customer acquisition costs to assess the sustainability of the revenue decline.
• Debt Maturity: Confirm the conversion terms and redemption risks associated with the remaining $1.0 billion 2027 Convertible Notes.
• Legal Exposure: Review the status of the Schneider and Stary securities litigation appeals and BetterHelp privacy lawsuits for potential financial impact.
• Restructuring Costs: Track the execution of announced efficiency initiatives and the timing of associated charges in Q4 2025.